According to EQL Pharma AB latest financial reports the total liabilities of 7JK is $12.82M, an increase of 14.60% to 2022. At the end of 2022 company had $11.19M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that EQL Pharma AB is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $12.82M | 14.60% |
2022 | $11.19M | 1.76% |
2021 | $11.00M | 158.77% |
2020 | $4.25M | 95.28% |
2019 | $2.18M | - |